National Contract for Monoclonal Antibody for Respiratory Syncytial Virus (RSV) Passive Immunisation for Infants - Pathfinder Programme 3
- Published
- 1 October 2026
- Estimated value
- €1
- Place of performance
- IE061
- Procedure
- Negotiated procedure
- Lots
- 1
- Notice number
- 00676444-2026
- Reference
- 78754bbd-e24a-40c9-b90d-336fbd35c0b4
- Official source
- Official source
CPV codes
- 33651600Vaccines
Description
In accordance with National Immunisation Advisory Committee (NIAC) advice, HSE Public Health: National Health Protection, with Access & Integration and the National Women and Infants Health Programme wish to put in place a contract for a monoclonal antibody, Nirsevimab (Beyfontus®) for a third pathfinder immunisation programme to protect all babies from RSV disease born from 1st March 2026 to 28th February 2027. RSV is a common virus that causes respiratory infections in young babies. Babies under three months old get sicker with RSV than older children. Each winter in Ireland one in two newborns babies will get RSV and many will need medical care from their GP or the emergency department of a children’s hospital. Four out of a hundred new born babies are hospitalised due to RSV with some babies needing special treatment in intensive care units. Nirsevimab is currently the best way to protect babies from RSV. This contract will supply 50,000 doses of this drug for passive immunisation over a seven month period during the RSV season.
Award criteria
- Cost — Negotiated
- Cost — Negotiated with sole authorised supplier
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Sanofi | €1 | — |
Official publications
- TED · 00676444-2026 · 1 October 2026
- OJS · 190/2026 · 1 October 2026
Other tenders from Health Service Executive (HSE)
- Supply and Delivery of Live Attenuated Influenza Vaccine (LAIV) 2026/2027 Flu Season
- Provision of Private Hospital Capacity to support Urgent and Emergency Care
- HSE 28162 Authorisation Scheme for the Provision of Home Support Services - Round 3
- HSE 29617 - Authorisation Scheme for the Provision of Home Support Services - Round 4
- Supply and Delivery of 6 in 1 (Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Inactivated Polio Vaccine, Haemophilus Influenza Type…
- Supply and Delivery of Enhanced (adjuvanted) Inactivated Influenza Vaccines for Older People
- Supply and Delivery of Human Seasonal Trivalent Influenza Vaccines
- HSE 18320 National Drawdown Framework Agreement for the Supply of Dental Consumables
- Higher Diploma Programme in Intellectual Disability Nursing for Registered Nurses
- The provision of Advanced Cardiac Life Support (ACLS) training (the 2-day provider course) to interns in the West-Northwest Intern Training…
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €1.
- Who is the buyer of this tender?
- The contracting authority is Health Service Executive (HSE) (European Union).
- How can I bid for public tenders in the European Union?
- Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new public tenders published in the European Union that match your business, every day.